Exact Mass: 571.3134696

Exact Mass Matches: 571.3134696

Found 368 metabolites which its exact mass value is equals to given mass value 571.3134696, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Endomorphin-2

(2S)-2-({[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-N-[(1S)-1-(C-hydroxycarbonimidoyl)-2-phenylethyl]-3-phenylpropanimidate

C32H37N5O5 (571.2794552)

Endomorphin-1 (H-Tyr-Pro-Trp-Phe-NH2) and endomorphin-2 (H-Tyr-Pro-Phe-Phe-NH2) are peptide amides with the highest known affinity and specificity for the mu-opioid receptor. [HMDB] Endomorphin-1 (H-Tyr-Pro-Trp-Phe-NH2) and endomorphin-2 (H-Tyr-Pro-Phe-Phe-NH2) are peptide amides with the highest known affinity and specificity for the mu-opioid receptor. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

Kinetensin 4-7

(2S)-2-({[(2S)-1-[(2S)-2-{[(2S)-2-amino-5-carbamimidamido-1-hydroxypentylidene]amino}-3-(1H-imidazol-5-yl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-3-(4-hydroxyphenyl)propanoate

C26H37N9O6 (571.2866662)

Kinetensin 4-7 is a fraction of kinetensin with only the Arg-His-Pro-Tyr peptide chain. Kinetensin is a nonapeptide, originally isolated from pepsin-treated plasma that shares some sequence homology with the C-terminal end of neurotensin, serum albumin, and angiotensin. It is a potent histamine releaser in rodents and may serve as an inflammatory mediator. Kinetensin 4-7 is a fraction of Kinetensin with only Arg-His-Pro-Tyr peptide chain.

Cholyltyrosine

3-(4-hydroxyphenyl)-2-(4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)propanoic acid

C33H49NO7 (571.3508844)

Cholyltyrosine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholyltyrosine consists of the bile acid cholic acid conjugated to the amino acid Tyrosine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholyltyrosine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholyltyrosine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

Chenodeoxycholyl-L-dopa

2-(4-{5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)-3-(3,4-dihydroxyphenyl)propanoic acid

C33H49NO7 (571.3508844)

Deoxycholyl-L-dopa

2-(4-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanamido)-3-(3,4-dihydroxyphenyl)propanoic acid

C33H49NO7 (571.3508844)

14-O-Anisoylneoline

C32H45NO8 (571.3145010000001)

AKOS037514937

C33H49NO7 (571.3508844)

11,13-O-diacetyl-9-glanduline

9-Deoxyglanduline 11,13-diacetate

C31H41NO9 (571.2781176000001)

Phe Ile His Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C27H41N9O5 (571.3230496)

Arg Leu Asn Arg

C23H45N11O6 (571.355411)

Ala Arg Gln Ala Leu

C24H45N9O7 (571.344178)

Arg Asn Ile Val Ala

C24H45N9O7 (571.344178)

Pro Val Glu Thr Leu

C26H45N5O9 (571.321712)

Asn Leu Arg Arg

C23H45N11O6 (571.355411)

Ser Phe Tyr Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoic acid

C27H37N7O7 (571.2754332)

Leu Arg Asn Arg

C23H45N11O6 (571.355411)

Pro Glu Ala Gln Lys

C24H41N7O9 (571.2965616)

4IU7YM4FUK

(2R,3R,4S,5S,6R)-2-[[(3S,6aR,11aS,11bR)-9-[(1S)-1-[(2S,3R,5S)-3-hydroxy-5-methylpiperidin-2-yl]ethyl]-10,11b-dimethyl-1,2,3,4,6,6a,11,11a-octahydrobenzo[a]fluoren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C33H49NO7 (571.3508844)

Veratrosine is a natural product found in Veratrum dahuricum with data available. Veratramine is a steroidal alkaloid extracted from the roots and rhizomes of Veratrum californicum[1].

veratrosine

C33H49NO7 (571.3508844)

Data obtained from an ethanol extract of Veratrum californicum. Separation was accomplished with reversed-phase high performance chromatography. Veratramine is a steroidal alkaloid extracted from the roots and rhizomes of Veratrum californicum[1].

Tyrosocholic Acid

N-(3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-oyl)-L-tyrosine

C33H49NO7 (571.3508844)

((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)tyrosine

"((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)tyrosine"

C33H49NO7 (571.3508844)

Pro Glu Ala Gln Lys

C24H41N7O9 (571.2965616)

NGRIL

Asn Gly Arg Ile Leu

C24H45N9O7 (571.344178)

RNIVA

Arg Asn Ile Val Ala

C24H45N9O7 (571.344178)

Endomorphin-2

(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide

C32H37N5O5 (571.2794552)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

Butikacin

C22H45N5O12 (571.306457)

C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

(2S,6S)-6,7-diamino-2-[[(4R)-4-carboxy-4-[[(2S)-2-(dodecanoylamino)propanoyl]amino]butanoyl]amino]-7-oxoheptanoic acid

C27H49N5O8 (571.3580954)

Plocabulin

A 1-acyl-sn-glycero-3-phospho-1D-myo-inositol(1-) in which the acyl group is specified as hexadecanoyl (palmitoyl); major species at pH 7.3.

PC(21:4)

PC(10:0_11:4)

C29H50NO8P (571.327387)

PE(24:4)

C33H49NO7 (571.3508844)

(2s)-n-[(3z,6s,9s,12r,13r)-3-ethylidene-5,8,11-trihydroxy-9-isopropyl-6,13-dimethyl-2-oxo-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-12-yl]-2-{[(2s)-3-oxobutan-2-yl]amino}-3-phenylpropanimidic acid

C29H41N5O7 (571.3005836)

14-o-anisoylneoline

C32H45NO8 (571.3145010000001)

{"Ingredient_id": "HBIN001537","Ingredient_name": "14-o-anisoylneoline","Alias": "NA","Ingredient_formula": "C32H45NO8","Ingredient_Smile": "CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6OC(=O)C7=CC=C(C=C7)OC)OC)O)OC)O)COC","Ingredient_weight": "571.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14317","TCMID_id": "1292","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "12068477","DrugBank_id": "NA"}

(2r,3s,4r,5r,6s,8s,13r,14r,16s,17s,18r)-5,14-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-7-oxo-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C31H41NO9 (571.2781176000001)

3,4,5,8,11-pentahydroxy-13-(3h-imidazol-4-ylmethyl)-7-[(4-methoxyphenyl)methyl]-10-(sec-butyl)-1h,2h,3h,4h,4ah,7h,10h,13h-pyridazino[1,6-a]1,4,7,10-tetraazacyclododecan-14-one

C27H37N7O7 (571.2754332)

(1s,2r,3r,4s,5r,6s,8r,9r,10r,13s,16s,17r,18r)-11-ethyl-8,18-dihydroxy-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 4-methoxybenzoate

C32H45NO8 (571.3145010000001)

(3r,4s,4as,7s,10r,13s)-10-[(2s)-butan-2-yl]-3,4,5,8,11-pentahydroxy-13-(3h-imidazol-4-ylmethyl)-7-[(4-methoxyphenyl)methyl]-1h,2h,3h,4h,4ah,7h,10h,13h-pyridazino[1,6-a]1,4,7,10-tetraazacyclododecan-14-one

(3r,4s,4as,7s,10r,13s)-10-[(2s)-butan-2-yl]-3,4,5,8,11-pentahydroxy-13-(3h-imidazol-4-ylmethyl)-7-[(4-methoxyphenyl)methyl]-1h,2h,3h,4h,4ah,7h,10h,13h-pyridazino[1,6-a]1,4,7,10-tetraazacyclododecan-14-one

C27H37N7O7 (571.2754332)

(1s,3r,4s,5r,8s,9r,10r,11r,14r,16s,17s,18s,19s)-4,10,19-tris(acetyloxy)-9-hydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl (2r)-2-methylbutanoate

(1s,3r,4s,5r,8s,9r,10r,11r,14r,16s,17s,18s,19s)-4,10,19-tris(acetyloxy)-9-hydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl (2r)-2-methylbutanoate

C31H41NO9 (571.2781176000001)

(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16r,17r,18s)-11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C32H45NO8 (571.3145010000001)

2-{[2-(1-{3-hydroxy-10,11b-dimethyl-1h,2h,3h,4h,6h,6ah,11h,11ah-cyclohexa[a]fluoren-9-yl}ethyl)-5-methylpiperidin-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H49NO7 (571.3508844)

(2s)-n-[(3z,6s,9s,12r,13r)-3-ethylidene-5,8,11-trihydroxy-9-isopropyl-6,13-dimethyl-2-oxo-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-12-yl]-2-{[(2r)-3-oxobutan-2-yl]amino}-3-phenylpropanimidic acid

C29H41N5O7 (571.3005836)

4,10,19-tris(acetyloxy)-9-hydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl 2-methylbutanoate

C31H41NO9 (571.2781176000001)

3-{1-[(13z)-8,11-dihydroxy-16-methoxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,16-pentaen-6-yl]-3-methyl-1-oxobutan-2-yl}-1,5-dimethylimidazolidin-4-one

C30H45N5O6 (571.336967)

(7s,10r,13r)-10-[(2r)-butan-2-yl]-3,4,5,8,11-pentahydroxy-13-(3h-imidazol-4-ylmethyl)-7-[(4-methoxyphenyl)methyl]-1h,2h,3h,4h,4ah,7h,10h,13h-pyridazino[1,6-a]1,4,7,10-tetraazacyclododecan-14-one

C27H37N7O7 (571.2754332)

(2r,3r,4s,5s,6r)-2-{[(2s,3r,5s)-2-[(1r)-1-[(3s,6ar,11as,11br)-3-hydroxy-10,11b-dimethyl-1h,2h,3h,4h,6h,6ah,11h,11ah-cyclohexa[a]fluoren-9-yl]ethyl]-5-methylpiperidin-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H49NO7 (571.3508844)

(1r,2r,3s,4s,5r,6s,8s,9s,10s,13s,14r,16s,17r,18r)-5,14-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-7-oxo-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

(1r,2r,3s,4s,5r,6s,8s,9s,10s,13s,14r,16s,17r,18r)-5,14-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-7-oxo-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C31H41NO9 (571.2781176000001)